Banco de Dados - artigo 1.xlsx

At the PesqClin laboratory – Hospital Universitário Onofre Lopes/ UFRN, the appropriate structure was set up to carry out all the steps necessary for data collection, according to the procedures and instruments: application of anamnesis on the history of personal and family diseases, the body mass was measured using a Sanny® digital scale according to the standardization described by Gordon (GORDON, C. C.; CHUMLEA, W. C.; ROCHE, A. F. Stature recumbert, lenght, and weight. In: LOHMAN, T. G.;ROCHE, A. F., 1988), height was measured using a Sanny® stadiometer as standardized by Gordon(GORDON, C. C.; CHUMLEA, W. C.; ROCHE, A. F. Stature recumbert, lenght, and weight. In: LOHMAN, T. G.;ROCHE, A. F., 1988), the abdominal/waist circumference was measured following the procedure described by Costa (COSTA, 2001), using Sanny® anthropometric metal tape.

BMI was calculated by dividing mass in kilograms by the square of height in meters. The ABSI was calculated according to the equation proposed by Krakauer and Krakauer (Krakauer & Krakauer, 2012).

The BRI was calculated following the equation proposed by Thomas et al (Thomas et al., 2013) BRI=364.2−365.5×  1−(WC/(2π))2/(0.5Height)2. WHtR was determined by dividing waist circumference (cm) by height (cm)(Pitanga & Lessa, 2006). 

               Blood pressure was measured with a semiautomatic device (OMRON – HEM 705 CP) following the criteria of the VI Brazilian Guidelines on Arterial Hypertension (2010), the final result being considered the average of three measurements performed with an interval of two minutes between each one.
               To standardize the biochemical evaluation, 10 ml blood samples were collected by puncture of the antecubital vein, always performed by the same professional, always between 7:00 and 8:00 am, after fasting for 12 hours. After peripheral blood collection, serum concentrations of fasting glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides were determined.
               All dosages mentioned above were performed by enzymatic-colorimetric assays for "in vitro" diagnoses, specific for each dosage, considering the cut-off values according to the NCEP-ATP III diagnostic criteria (Expert Panel on Detection, Evaluation, 2001) for metabolic syndrome, triglycerides ≥150mg/dl, HDL (male) < 40mg/dl and HDL (female) < 50mg/dl, fasting glucose ≥100mg/dl.
               For the analysis of dosages, commercial kits Labtest Diagnóstica-SA® were used, in the Labmax Plenno equipment (Labtest®, Lagoa Santa/MG) and for the determination of LDL-cholesterol levels, the Martin formula was used (Martin et al., 2013) (total cholesterol – HDL-cholesterol - [triglycerides/factor]) (factor/;3.1 to 11.9).